Australia the world's fastest-growing medicinal cannabis market

Australia the world's fastest-growing medicinal cannabis market

A leading supplier of medicinal cannabis increased its Australian patient numbers by 27 per cent over a three-week period in April, representing 10 new patients every business day.

In an interview with Business News Australia earlier this month, Althea Group (ASX: AGH) managing director and founder Josh Fegan said patient numbers were "starting to spike", supported by an outreach program with doctors to persuade them of medicinal cannabis' benefits while providing technology to track results. 

Today the company announced it had achieved the 650-patient milestone with 140 patients added between 4-26 April, and 145 healthcare professionals have now prescribed Althea's products.

"The rapid uptake has been driven by our Medical Science Liaison (MSL) team on the ground and Althea Concierge, the Company's proprietary platform that allows patients, doctors and pharmacies to manage their medicinal cannabis needs in Australia," says Althea COO Patty Holmes.

"A key benefit of Althea Concierge is that it is able to greatly reduce application times for HCP's looking to prescribe medicinal cannabis."

Holmes adds the company is recruting more MSLs due to increased demand for its services, while in the update Althea pointed to research from Cannvalate Australia showing our country has the fastest-growing market for medicinal cannabis globally in terms of percentage month-on-month growth.

"Following the strong growth in Q3 FY19 that saw us pass the 500-patient mark, we are very happy to see further acceleration in the growth rate of patients in the first weeks of Q4 FY19," says Fegan.

"Our team continues to focus on educating Healthcare Professionals about the benefits of Althea's pharma-grade medicinal cannabis products and providing support to the patients who require them.

"The ease of use of Althea Concierge has also been a key factor in our success and is complementary to our RACGP and ACRRM accredited medicinal education portal, MEDIC. I look forward to providing the next update on Althea's increasing uptake soon."

AGH shares were up 6.38 per cent this morning at $0.50.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Enjoyed this article?

Don't miss out on the knowledge and insights to be gained from our daily news and features.

Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.

Support independent journalism and stay informed with stories that matter to you.

Subscribe now and get 50% off your first year!

Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

“Not our desired outcome”: Telix withdraws from $300m Nasdaq IPO

“Not our desired outcome”: Telix withdraws from $300m Nasdaq IPO

Telix Pharmaceuticals (ASX: TLX), one of the nation’s largest...

CommBank joins new ‘intelligence loop’ to combat SMS phishing scams

CommBank joins new ‘intelligence loop’ to combat SMS phishing scams

In an effort to reduce the number of SMS phishing scam victims...

Stralis Aircraft secures funding to make commercial hydrogen planes a reality

Stralis Aircraft secures funding to make commercial hydrogen planes a reality

Brisbane-based Stralis Aircraft has become one step closer to its a...

‘Gone the long yards’: Luxury boatbuilder Maritimo a stayer in local manufacturing

‘Gone the long yards’: Luxury boatbuilder Maritimo a stayer in local manufacturing

In an era when Australia’s mass-production car industry is a ...